Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from

Sameer K Mehta1, Andrew D Frutkin, Jason B Lindsey

  • 1Division of Cardiovascular Research, Mid America Heart Institute, Saint Luke's Hospital, Kansas City, MO 64111, USA.

Insights

Bleeding after percutaneous coronary intervention (PCI) is common. A new risk algorithm identifies key clinical factors to predict bleeding events in PCI patients, aiding treatment decisions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Risk Prediction

Background:

  • Bleeding complications following percutaneous coronary intervention (PCI) are linked to worse patient outcomes, including increased mortality and healthcare costs.
  • Identifying patients at high risk for bleeding is crucial for optimizing treatment strategies and improving patient safety after PCI.

Purpose of the Study:

  • To identify baseline clinical characteristics associated with bleeding complications after PCI.
  • To develop a simplified and clinically useful algorithm for predicting bleeding risk in patients undergoing PCI.

Main Methods:

  • Analysis of data from 302,152 PCI procedures across 440 US centers within the National Cardiovascular Data Registry.
  • Development of a risk prediction model using 15 clinical elements identified in an 80% training cohort, validated on the remaining 20% of the data.
  • Definition of bleeding complications included transfusion, prolonged hospital stay, or a significant hemoglobin drop (>3.0 g/dL).

Main Results:

  • Bleeding complications occurred in 2.4% of patients undergoing PCI.
  • Key predictors of bleeding included age, gender, heart failure history, reduced glomerular filtration rate, peripheral vascular disease, prior PCI status, heart failure severity (NYHA/CCS Class IV), and acute coronary syndromes (STEMI, NSTEMI), and cardiogenic shock.
  • A validated risk algorithm stratified patients into categories with increasing bleeding rates (0.7% for scores ≤7, 1.8% for 8-17, and 5.1% for ≥18).

Conclusions:

  • Baseline clinical factors significantly associated with post-PCI bleeding have been identified.
  • A simplified, clinically actionable risk algorithm has been developed to estimate bleeding risk in patients undergoing PCI.
  • This risk prediction tool has the potential to guide therapeutic decision-making and improve outcomes for patients receiving PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...